2023年11月2日,津药药业(600488)公告,近日,公司收到国家药监局核准签发的曲伏前列素《化学原料药上市申请批准通知书》。曲伏前列素用于降低开角型青光眼或高眼压症患者升高的眼压。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.